One of the most mysterious forms of life may turn out to be a rich and untapped source of antibacterial drugs.

The pharmaceutical industry has withdrawn from the ‘antibiotic space.’ Is it time for research universities to step in?

This is the inescapable conclusion of Michael Kinch’s adventures in data mining

Thermo Fisher Scientific has developed a high-resolution hydrophobic interaction chromatography (HIC) method that can separate a fusion protein from a truncated version and a structural isomer.

Recently identified cell-cycle controls are targets for new drugs that fight infections by shutting down division.

The previously unrecognized layer of biology could offer new drug targets.

As lab manager at the University of Pittsburgh Drug Discovery Institute (UPDDI), Celeste Reese and her team use high-content imaging strategies and work with many other labs both within the university and outside the university on a wide range of projects.

John Wiley & Sons, Inc., a global provider of knowledge and knowledge-enabled solutions that improve outcomes in research, professional practice, and education, announced today that it has acquired SimBioSys Inc., a provider of scientific software tools that facilitate the drug discovery process. Terms were not disclosed.

Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a three-year comprehensive alliance to develop first-in-class therapeutics for the treatment of cardiovascular-metabolic diseases. The collaboration is built on an open-innovation model to bridge the gap between target discovery and pre-clinical drug development.